Cover Image
市場調查報告書

血液成份分離機的全球市場:2015∼2019年

Global Apheresis Equipment Market 2015-2019

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 341156
出版日期 內容資訊 英文 71 Pages
訂單完成後即時交付
價格
Back to Top
血液成份分離機的全球市場:2015∼2019年 Global Apheresis Equipment Market 2015-2019
出版日期: 2015年09月30日 內容資訊: 英文 71 Pages
簡介

血液分離術是由全血中分離出血小板、紅血球、血漿等之介入流程。將捐贈者及患者的血液透過血液成份分離機加工而成。血液成份分離機是用來將血液高速回轉以將必要成分由其他成分中分離。全球血液成份分離機市場預測在2014∼2019年間將以年複合成長率10.72%擴大。

本報告提供全球血液成份分離機市場現狀及2015∼2019年的成長預測相關調查,為您彙整市場規模,收益趨勢,各產品,各地區趨勢,及主要供應商簡介等資料。

第1章 摘要整理

第2章 本報告的範圍

第3章 市場調查方法

第4章 簡介

第5章 市場環境

  • 市場概要
  • 市場規模與預測
  • 波特的五力分析

第6章 血球分離:概要

第7章 臨床的血球分離的ASFA指南

  • 類別1
  • 類別2
  • 類別3
  • 類別4

第8章 各技術市場區隔

  • 離心分離
  • 膜過濾
  • 透過離心分離的全球血液成份分離機市場
  • 透過膜過濾的全球血液成份分離機市場

第9章 治療別市場區隔

  • 血漿置換
  • 分離術血小板
  • 分離術紅血球
  • 光化學療法
  • 其他

第10章 各產品市場區隔

  • 消耗品
  • 設備

第11章 各地區市場區隔

  • 南北美洲
  • 歐洲·中東·非洲
  • 亞太地區

第12章 推動市場的要素

  • 生物醫藥品製造商的血漿需求
  • 技術的進步
  • 血球分離勝過全血捐血的優點
  • 血液疾病發病率上升

第13章 推動市場要素的影響

第14章 市場課題

  • 血球分離的風險
  • 血球分離的高成本
  • 嚴格的法律規章政策
  • 捐血者的募集和確保的問題

第15章 促進要素與課題的影響

第16章 市場趨勢

  • 用途的擴大
  • 自動採血系統的使用
  • 跟血庫,醫院的合作

第17章 供應商環境

  • 競爭模式
  • 市場佔有率分析:2014年
  • 其他值得注意的供應商

第18章 主要供應商分析

  • 旭化成醫學
  • Haemonetics
  • Fenwal
  • Macopharma
  • Terumo BCT

第19章 附錄

第20章 關於Technavio

圖表

目錄
Product Code: IRTNTR7102

About apheresis

Apheresis is an invasive process that involves the separation of components such as platelets, RBC, plasma, and other components from whole blood. In this procedure, the blood of a donor or a patient is passed through an apheresis machine or a blood cell separator. The apheresis equipment spins the blood to separate the required component from other blood components. A selected part of the blood is removed, and the remaining elements are returned to the donor or the patient. It involves the use of devices and disposables along with separation technologies such as centrifugation and membrane filtration. The equipment used in apheresis include manual and automated systems.

Technavio's analysts forecast the global apheresis equipment market to grow at a CAGR of 10.72% over the period 2014-2019.

Covered in this report

This report covers the present scenario and the growth prospects of the global apheresis equipment market for 2015-2019. To calculate the market size, the report considers the revenue generated from the sales of various devices and disposables used in apheresis that are available in the market. The two major technologies discussed in the report are centrifugation and membrane filtration.

Technavio's report, Global Apheresis Equipment Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report also covers the landscape of the global apheresis equipment market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

Key regions

  • Americas
  • APAC
  • EMEA

Key vendors

  • Asahi Kasei Medical
  • Fenwal
  • Haemonetics
  • Macopharma
  • Terumo BCT

Other Prominent Vendors

  • Cerus
  • Grifols
  • HemaCare
  • Hemagen Diagnostics
  • Immucor
  • Kawasumi Laboratories
  • Therakos

Key market driver

  • High demand for plasma in biopharmaceutical companies
  • For a full, detailed list, view our report

Key market challenge

  • Risks associated with apheresis
  • For a full, detailed list, view our report

Key market trend

  • Expanding applications of apheresis
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2019 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

Table of Contents

PART 01: Executive summary

  • Highlights

PART 02: Scope of the report

  • Market overview
  • Top-vendor offerings

PART 03: Market research methodology

  • Research methodology
  • Economic indicators

PART 04: Introduction

  • Key market highlights

PART 05: Market landscape

  • Market overview
  • Market size and forecast
  • Five forces analysis

PART 06: Apheresis: An overview

PART 07: ASFA guidelines for apheresis in clinical practice

  • Category I
  • Category II
  • Category III
  • Category IV

PART 08: Market segmentation by technology

  • Centrifugation
  • Membrane filtration
  • Global apheresis equipment market by centrifugation
  • Global apheresis equipment market by membrane filtration

PART 09: Market segmentation by procedure

  • Plasmapheresis
  • Plateletpheresis
  • Erythrocytapheresis
  • Photopheresis
  • Others

PART 10: Market segmentation by product

  • Disposables
  • Devices

PART 11: Geographical segmentation

  • Apheresis equipment market in Americas
  • Apheresis equipment market in EMEA
  • Global apheresis equipment market in APAC

PART 12: Market drivers

  • Demand for blood plasma in biopharmaceutical companies
  • Advances in technology
  • Advantages of apheresis over whole blood donation
  • Increased incidence of hematological disorders

PART 13: Impact of drivers

PART 14: Market challenges

  • Risks associated with apheresis
  • High cost of apheresis
  • Stringent regulatory policies
  • Issues in recruiting and retaining blood donors

PART 15: Impact of drivers and challenges

PART 16: Market trends

  • Increase in applications
  • Use of automated blood collection systems
  • Collaboration among blood banks and hospitals

PART 17: Vendor landscape

  • Competitive scenario
  • Market share analysis 2014
  • Other prominent vendors

PART 18: Key vendor analysis

  • Asahi Kasei Medical
  • Haemonetics
  • Fenwal
  • Macopharma
  • Terumo BCT

PART 19: Appendix

  • List of abbreviations

PART 20: Explore Technavio

List of Exhibits

  • Exhibit 01: Product offerings
  • Exhibit 02: Global apheresis equipment market 2014-2019 ($ millions)
  • Exhibit 03: Five forces analysis
  • Exhibit 04: Mechanism of apheresis
  • Exhibit 05: History of apheresis
  • Exhibit 06: Size and specific weight of various blood components
  • Exhibit 07: Global apheresis equipment market segmentation by technology
  • Exhibit 08: Working of centrifugation
  • Exhibit 09: Working of membrane filtration
  • Exhibit 10: Difference between centrifugation and membrane filtration
  • Exhibit 11: Global equipment market by centrifugation 2014-2019 ($ millions)
  • Exhibit 12: Global apheresis equipment market by membrane filtration 2014-2019 ($ millions)
  • Exhibit 13: Global apheresis equipment market segmentation by technology 2014
  • Exhibit 14: Global apheresis equipment market segmentation by procedure
  • Exhibit 15: Global apheresis equipment market segmentation by procedure 2014
  • Exhibit 16: Global apheresis equipment market segmentation by product
  • Exhibit 17: Global apheresis equipment market segmentation by product 2014
  • Exhibit 18: Global apheresis equipment market segmentation by geography 2014
  • Exhibit 19: Apheresis equipment market in Americas 2014-2019 ($ millions)
  • Exhibit 20: Apheresis equipment market in EMEA 2014-2019 ($ millions)
  • Exhibit 21: Apheresis equipment market in APAC 2014-2019 ($ millions)
  • Exhibit 22: Global apheresis equipment market by geography 2014-2019 ($ millions)
  • Exhibit 23: Global apheresis equipment market by geography 2014-2019
  • Exhibit 24: Comparison of whole blood donors and blood component donors (apheresis)
  • Exhibit 25: Impact of drivers
  • Exhibit 26: Impact of drivers and challenges
  • Exhibit 27: Asahi Kasei Medical: Key takeaways
  • Exhibit 28: Haemonetics: Key takeaways
  • Exhibit 29: Fenwal: Key takeaways
  • Exhibit 30: Macopharma: Key takeaways
  • Exhibit 31: Terumo BCT: Key takeaways
  • Exhibit 32: Asahi Kasei Medical: Business segmentation by revenue 2014
  • Exhibit 33: Asahi Kasei Medical: Business segmentation by revenue FY2013 and FY2014 ($ billions)
  • Exhibit 34: Asahi Kasei Medical: Geographical segmentation by revenue 2014
  • Exhibit 35: Haemonetics: Product segmentation by revenue 2015
  • Exhibit 36: Haemonetics: Product segmentation by revenue 2014 and 2015 ($ millions)
  • Exhibit 37: Haemonetics: Geographical segmentation by revenue 2014
  • Exhibit 38: Terumo BCT: Business segmentation by revenue 2014
  • Exhibit 39: Terumo BCT: Geographical segmentation by revenue 2014
Back to Top